Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan

Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan

Abstract Background There is an urgent need for treatments that can shorten hospitalization and lower the risk of secondary infection and death in patients with corona disease. The ProPac-COVID trial evaluates whether combination therapy with macrolide azithromycin and hydroxychloroquine via anti-in...

Full description

Bibliographic Details
Main Authors: Pradeesh Sivapalan, Charlotte Suppli Ulrik, Therese Sophie Lappere, Josefin Viktoria Eklöf, Saher Burhan Shaker, Uffe Christian Steinholtz Bødtger, Andrea Browatzki, Christian Niels Meyer, Ulla Møller Weinreich, Christian B. Laursen, Tor Biering-Sørensen, Filip Krag Knop, Jens D. Lundgren, Jens-Ulrik Stæhr Jensen
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Trials
Subjects:
Detailed statistical analysis plan
Randomized controlled trial
Infectious diseases
Safety
Hydroxychloroquine
Azithromycin
Online Access:http://link.springer.com/article/10.1186/s13063-020-04795-0

Internet

http://link.springer.com/article/10.1186/s13063-020-04795-0

Similar Items